Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 25.


Eagle, Gina L, Herbert, John MJ, Zhuang, Jianguo ORCID: 0000-0003-3245-0789, Oates, Melanie, Khan, Umair T, Kitteringham, Neil R, Clarke, Kim, Park, B Kevin ORCID: 0000-0001-8384-824X, Pettitt, Andrew R, Jenkins, Rosalind E
et al (show 1 more authors) (2021) Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells. Scientific Reports, 11 (1). p. 2932.


Lim, Yeong Jer ORCID: 0000-0002-9022-2904, Khan, Umair, Karpha, Indrani, Ross, Andrew, Saif, Muhammad, Remberger, Mats, Kalakonda, Nagesh, Pettitt, Andrew R and Floisand, Yngvar
(2022) COVID-19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta-analysis. EJHaem, 3 (3). pp. 862-872.


Pettitt, Andrew R
(1999) Cell survival, P53 dysfunction and nucleoside action in chronic lymphocytic leukaemia. PhD thesis, University of Liverpool.


Khan, Umair T ORCID: 0000-0002-9470-3481, Racu-Amoasii, Igor, Arumainathan, Arvind, Meswani, Ushma, Pettitt, Andrew R and Menon, Geetha
(2018) Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis. BRITISH JOURNAL OF HAEMATOLOGY, 183 (3). p. 345.


Flinn, Ian W, Miller, Carole B, Ardeshna, Kirit M, Tetreault, Scott, Assouline, Sarit E, Mayer, Jiri, Merli, Michele, Lunin, Scott D, Pettitt, Andrew R ORCID: 0000-0002-0907-8950, Nagy, Zoltan
et al (show 13 more authors) (2019) DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 37 (11). 912-+.


Hargreaves, Chantal E, Iriyama, Chisako, Rose-Zerilli, Matthew JJ, Nagelkerke, Sietse Q, Hussain, Khiyam, Ganderton, Rosalind, Lee, Charlotte, Machado, Lee R, Hollox, Edward J, Parker, Helen
et al (show 11 more authors) (2016) Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus (vol 10, e0142379, 2015). PLOS ONE, 11 (3). e0145040-.


Sharman, Jeff P, Coutre, Steven E, Furman, Richard R, Cheson, Bruce D, Pagel, John M, Hillmen, Peter, Barrientos, Jacqueline C, Zelenetz, Andrew D, Kipps, Thomas J, Flinn, Ian W
et al (show 14 more authors) (2019) Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology, 37 (16). pp. 1391-1402.


Law, Philip J, Berndt, Sonja I, Speedy, Helen E, Camp, Nicola J, Sava, Georgina P, Skibola, Christine F, Holroyd, Amy, Vijai, Joseph, Sunter, Nicola J, Nieters, Alexandra
et al (show 88 more authors) (2017) Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nature Communications, 8 (1). 14175-.


Law, Philip J, Sud, Amit, Mitchell, Jonathan S, Henrion, Marc, Orlando, Giulia, Lenive, Oleg, Broderick, Peter, Speedy, Helen E, Johnson, David C, Kaiser, Martin
et al (show 31 more authors) (2017) Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. SCIENTIFIC REPORTS, 7 (1). 41071-.


Rose-Zerilli, Matthew John Jerome, Parker, Helen, Larrayoz, Marta, Clifford, Ruth, Blakemore, Stuart, Edelmann, Jennifer, Gibson, Jane, Wang, Jun, Ljungstrom, Viktor, Chaplin, Tracy
et al (show 26 more authors) (2015) Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia. , England.


Schuh, Anna H, Parry-Jones, Nilima, Appleby, Niamh, Bloor, Adrian, Dearden, Claire E, Fegan, Christopher, Follows, George, Fox, Christopher P, Iyengar, Sunil, Kennedy, Ben
et al (show 7 more authors) (2018) Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). pp. 344-359.


Essa, Hani, Pettitt, Andrew R and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2020) Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated. JOURNAL OF HUMAN HYPERTENSION, 35 (4). pp. 301-303.


Middle, Stephen, Coupland, Sarah E ORCID: 0000-0002-1464-2069, Taktak, Azzam, Kidgell, Victoria, Slupsky, Joseph R ORCID: 0000-0002-7410-9004, Pettitt, Andrew R and Till, Kathleen J ORCID: 0000-0002-3172-5771
(2015) Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1phosphate receptors and integrins. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 4 (1). 10-.


Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael and Furman, Richard R
(2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. HAEMATOLOGICA, 105 (10). E519-E522.


Trotman, Judith and Pettitt, Andrew R
(2022) Is it time for PET-guided therapy in follicular lymphoma? BLOOD, 139 (11). pp. 1631-1641.


Linley, Adam J ORCID: 0000-0002-8176-5560, Karydis, Laura I, Mondru, Anil K, D'Avola, Annalisa, Al Shmrany, Humood, Cicconi, Silvia, Griffin, Rebecca, Forconi, Francesco, Pettitt, Andrew R, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360
et al (show 7 more authors) (2021) Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells. CLINICAL CANCER RESEARCH, 27 (20). pp. 5647-5659.


Till, Kathleen J ORCID: 0000-0002-3172-5771, Allen, John C, Talab, Fatima, Lin, Ke, Allsup, David, Cawkwell, Lynn, Bentley, Alison, Ringshausen, Ingo, Duckworth, Andrew D, Pettitt, Andrew R
et al (show 2 more authors) (2017) Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome. SCIENTIFIC REPORTS, 7 (1). 16784-.


Pettitt, Andrew R, Jackson, Richard, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Polydoros, Fotis, Yap, Christina, Dodd, James, Bickerstaff, Matthew, Stackpoole, Michael, Khan, Umair T ORCID: 0000-0002-9470-3481, Carruthers, Stacey
et al (show 16 more authors) (2020) Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial. HAEMATOLOGICA, 105 (12). pp. 2868-2871.


Sherratt, Frances C ORCID: 0000-0003-4147-9305, Fisher, Peter ORCID: 0000-0002-7388-720X, Mathieson, Amy, Cherry, Mary G, Pettitt, Andrew R and Young, Bridget ORCID: 0000-0001-6041-9901
(2022) Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study. TRIALS, 23 (1). 509-.


Johnson, Gillian G, Carr, Daniel F, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Pettitt, Andrew R
(2014) Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold? PHARMACOGENOMICS, 15 (7). pp. 897-900.


Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023) Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib. Scientific reports, 13 (1). p. 3793.


Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023) Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib. Scientific reports, 13 (1). 3793-.


Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023) Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib. Scientific reports, 13 (1). 3793-.


Robbe, Pauline, Ridout, Kate E, Vavoulis, Dimitrios V, Dreau, Helene, Kinnersley, Ben, Denny, Nicholas, Chubb, Daniel, Appleby, Niamh, Cutts, Anthony, Cornish, Alex J
et al (show 33 more authors) (2022) Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. NATURE GENETICS, 54 (11). 1675-+.


Kreuzer, Karl-Anton, Furman, Richard R, Stilgenbauer, Stephan, Dubowy, Ronald L, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara
et al (show 4 more authors) (2020) The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. Leukemia, 34 (1). pp. 296-300.

This list was generated on Sat Mar 9 15:25:28 2024 GMT.